Melatonin effects on luteinizing hormone in postmenopausal women: a pilot clinical trial NCT00288262
<p>Abstract</p> <p>Background</p> <p>In many mammals, the duration of the nocturnal melatonin elevation regulates seasonal changes in reproductive hormones such as luteinizing hormone (LH). Melatonin's effects on human reproductive endocrinology are uncertain. It i...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2006-05-01
|
| Series: | BMC Women's Health |
| Online Access: | http://www.biomedcentral.com/1472-6874/6/8 |
| _version_ | 1818760293852905472 |
|---|---|
| author | Kline Lawrence E Kripke Daniel F Shadan Farhad F Dawson Arthur Poceta J Steven Elliott Jeffrey A |
| author_facet | Kline Lawrence E Kripke Daniel F Shadan Farhad F Dawson Arthur Poceta J Steven Elliott Jeffrey A |
| author_sort | Kline Lawrence E |
| collection | DOAJ |
| description | <p>Abstract</p> <p>Background</p> <p>In many mammals, the duration of the nocturnal melatonin elevation regulates seasonal changes in reproductive hormones such as luteinizing hormone (LH). Melatonin's effects on human reproductive endocrinology are uncertain. It is thought that the same hypothalamic pulse generator may both trigger the pulsatile release of GnRH and LH and also cause hot flashes. Thus, if melatonin suppressed this pulse generator in postmenopausal women, it might moderate hot flashes. This clinical trial tested the hypothesis that melatonin could suppress LH and relieve hot flashes.</p> <p>Methods</p> <p>Twenty postmenopausal women troubled by hot flashes underwent one week of baseline observation followed by 4 weeks of a randomized controlled trial of melatonin or matched placebo. The three randomized treatments were melatonin 0.5 mg 2.5–3 hours before bedtime, melatonin 0.5 mg upon morning awakening, or placebo capsules. Twelve of the women were admitted to the GCRC at baseline and at the end of randomized treatment for 24-hour sampling of blood for LH. Morning urine samples were collected twice weekly to measure LH excretion. Subjective responses measured throughout baseline and treatment included sleep and hot flash logs, the CESD and QIDS depression self-ratings, and the SAFTEE physical symptom inventory.</p> <p>Results</p> <p>Urinary LH tended to increase from baseline to the end of treatment. Contrasts among the 3 randomized groups were statistically marginal, but there was relative suppression combining the groups given melatonin as contrasted to the placebo group (p < 0.01 one-tailed, Mann-Whitney U = 14.) Similar but not significant results were seen in blood LH. There were no significant contrasts among groups in hot flashes, sleep, depression, or side-effect measures and no significant adverse effects of any sort.</p> <p>Conclusion</p> <p>The data are consistent with the hypothesis that melatonin suppresses LH in postmenopausal women. An effect related to the duration of nocturnal melatonin elevation is suggested. Effects of melatonin on reproductive endocrinology should be studied further in younger women and in men. Larger studies of melatonin effects on postmenopausal symptoms would be worthwhile.</p> |
| first_indexed | 2024-12-18T06:56:19Z |
| format | Article |
| id | doaj.art-c14d0c33775f4ff49337877fd45e7927 |
| institution | Directory Open Access Journal |
| issn | 1472-6874 |
| language | English |
| last_indexed | 2024-12-18T06:56:19Z |
| publishDate | 2006-05-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Women's Health |
| spelling | doaj.art-c14d0c33775f4ff49337877fd45e79272022-12-21T21:17:10ZengBMCBMC Women's Health1472-68742006-05-0161810.1186/1472-6874-6-8Melatonin effects on luteinizing hormone in postmenopausal women: a pilot clinical trial NCT00288262Kline Lawrence EKripke Daniel FShadan Farhad FDawson ArthurPoceta J StevenElliott Jeffrey A<p>Abstract</p> <p>Background</p> <p>In many mammals, the duration of the nocturnal melatonin elevation regulates seasonal changes in reproductive hormones such as luteinizing hormone (LH). Melatonin's effects on human reproductive endocrinology are uncertain. It is thought that the same hypothalamic pulse generator may both trigger the pulsatile release of GnRH and LH and also cause hot flashes. Thus, if melatonin suppressed this pulse generator in postmenopausal women, it might moderate hot flashes. This clinical trial tested the hypothesis that melatonin could suppress LH and relieve hot flashes.</p> <p>Methods</p> <p>Twenty postmenopausal women troubled by hot flashes underwent one week of baseline observation followed by 4 weeks of a randomized controlled trial of melatonin or matched placebo. The three randomized treatments were melatonin 0.5 mg 2.5–3 hours before bedtime, melatonin 0.5 mg upon morning awakening, or placebo capsules. Twelve of the women were admitted to the GCRC at baseline and at the end of randomized treatment for 24-hour sampling of blood for LH. Morning urine samples were collected twice weekly to measure LH excretion. Subjective responses measured throughout baseline and treatment included sleep and hot flash logs, the CESD and QIDS depression self-ratings, and the SAFTEE physical symptom inventory.</p> <p>Results</p> <p>Urinary LH tended to increase from baseline to the end of treatment. Contrasts among the 3 randomized groups were statistically marginal, but there was relative suppression combining the groups given melatonin as contrasted to the placebo group (p < 0.01 one-tailed, Mann-Whitney U = 14.) Similar but not significant results were seen in blood LH. There were no significant contrasts among groups in hot flashes, sleep, depression, or side-effect measures and no significant adverse effects of any sort.</p> <p>Conclusion</p> <p>The data are consistent with the hypothesis that melatonin suppresses LH in postmenopausal women. An effect related to the duration of nocturnal melatonin elevation is suggested. Effects of melatonin on reproductive endocrinology should be studied further in younger women and in men. Larger studies of melatonin effects on postmenopausal symptoms would be worthwhile.</p>http://www.biomedcentral.com/1472-6874/6/8 |
| spellingShingle | Kline Lawrence E Kripke Daniel F Shadan Farhad F Dawson Arthur Poceta J Steven Elliott Jeffrey A Melatonin effects on luteinizing hormone in postmenopausal women: a pilot clinical trial NCT00288262 BMC Women's Health |
| title | Melatonin effects on luteinizing hormone in postmenopausal women: a pilot clinical trial NCT00288262 |
| title_full | Melatonin effects on luteinizing hormone in postmenopausal women: a pilot clinical trial NCT00288262 |
| title_fullStr | Melatonin effects on luteinizing hormone in postmenopausal women: a pilot clinical trial NCT00288262 |
| title_full_unstemmed | Melatonin effects on luteinizing hormone in postmenopausal women: a pilot clinical trial NCT00288262 |
| title_short | Melatonin effects on luteinizing hormone in postmenopausal women: a pilot clinical trial NCT00288262 |
| title_sort | melatonin effects on luteinizing hormone in postmenopausal women a pilot clinical trial nct00288262 |
| url | http://www.biomedcentral.com/1472-6874/6/8 |
| work_keys_str_mv | AT klinelawrencee melatonineffectsonluteinizinghormoneinpostmenopausalwomenapilotclinicaltrialnct00288262 AT kripkedanielf melatonineffectsonluteinizinghormoneinpostmenopausalwomenapilotclinicaltrialnct00288262 AT shadanfarhadf melatonineffectsonluteinizinghormoneinpostmenopausalwomenapilotclinicaltrialnct00288262 AT dawsonarthur melatonineffectsonluteinizinghormoneinpostmenopausalwomenapilotclinicaltrialnct00288262 AT pocetajsteven melatonineffectsonluteinizinghormoneinpostmenopausalwomenapilotclinicaltrialnct00288262 AT elliottjeffreya melatonineffectsonluteinizinghormoneinpostmenopausalwomenapilotclinicaltrialnct00288262 |